Alexis Retractor for Hip Arthritis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether using the Alexis wound retractor (a surgical tool) during hip replacement surgery improves wound healing and reduces infection risk. Participants will undergo surgery with either the Alexis retractor or a standard tool. The trial targets individuals receiving their first hip replacement through a specific front-side approach. Those with previous hip surgeries on either hip or specific drug allergies are not eligible. This research could enhance recovery experiences for future hip surgery patients. As an unphased trial, it offers participants the chance to contribute to advancements in surgical techniques that may improve recovery for future patients.
What prior data suggests that the Alexis Retractor is safe for hip arthroplasty?
Research has shown that the Alexis retractor is generally safe for surgeries like hip replacements. Studies have found that it not only protects the surgical area but also helps prevent thick scars, indicating it is well-tolerated during surgery.
While specific data on problems related to the Alexis retractor is lacking, its use in surgeries suggests safety. Surgeons often choose it because it can help wounds heal better, signaling its reliability and safety in surgical settings.12345Why are researchers excited about this trial?
Unlike the standard of care, which typically uses standard retractors during hip surgeries, the Alexis Retractor is unique because it offers a novel approach to maintaining a clear surgical field. Researchers are excited about this device because it provides 360-degree access and protection to the surgical site, potentially reducing tissue trauma and improving healing times. This retractor could lead to more efficient surgeries and better postoperative outcomes for patients with hip arthritis.
What evidence suggests that the Alexis Retractor is effective for hip arthritis?
Studies have shown that the Alexis retractor, which participants in this trial may receive, can improve wound healing during hip replacement surgeries. Research indicates that this device protects the wound and lowers the risk of hypertrophic scarring. Another study found that this retractor might help prevent infections at the surgical site. Initial findings suggest that this tool reduces damage to wound edges, resulting in better-looking scars. Overall, evidence supports the effectiveness of the Alexis retractor in enhancing outcomes after hip surgery. Participants in the other arm of this trial will undergo surgery using a standard retractor without the Alexis device.23678
Who Is on the Research Team?
Victor H Hernandez, MD, MSc
Principal Investigator
University of Miami Department of Orthopaedics
Are You a Good Fit for This Trial?
This trial is for patients who are having their first total hip replacement through a direct anterior approach. It's not for those who've had previous open surgery on the same hip or a hip replacement on the other side, nor for people allergic to drugs used in the University of Miami's standard hip replacement protocol.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgery
Participants undergo total hip arthroplasty using either the Alexis wound retractor or a standard retractor
Postoperative Monitoring
Participants are monitored for delayed wound healing and postoperative complications
Follow-up
Participants are monitored for long-term outcomes including scar assessment and hip function
What Are the Treatments Tested in This Trial?
Interventions
- Alexis Retractor
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Miami
Lead Sponsor